(Q42543676)

2 November 2017

Effects of ondansetron administration on opioid withdrawal syndrome observed in rats (English)

1 reference

opioid withdrawal syndrome

2 November 2017

0 references

1 reference

Pinelli A

1

1 reference

2 November 2017

Trivulzio S

series ordinal

2

1 reference

2 November 2017

Tomasoni L

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

European Journal of Pharmacology

2 November 2017

1 reference

2 November 2017

340

1 reference

2 November 2017

2-3

1 reference

2 November 2017

111-119

1 reference

5-HT3 receptors antagonists block morphine- and nicotine- but not amphetamine-induced place-preference conditioning.

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Voluntary oral morphine self-administration in rats: effect of haloperidol or ondansetron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Evidence for a receptor supersensitivity following impairment of central serotoninergic activity in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Astra Award Lecture. The psychopharmacology of 5-HT3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

The role of 5-HT in the expression of morphine withdrawal in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Cerebral cortical 5-HT1 and 5-HT2 receptors of morphine tolerant-dependent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

5-HT3 antagonists reduce morphine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Prevention by the 5-HT3 receptor antagonist, ondansetron, of morphine-dependence and tolerance in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

The role of central serotoninergic neurotransmission in the morphine abstinence syndrome in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Narcotic dependence, narcotic action and dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Ketanserin and pirenperone attenuate acute morphine withdrawal in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Multiple Mechanisms of withdrawal from Opioid Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats: relation to blockade of naloxone precipitated jumping by serotonin agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Changes of physical morphine dependence in rats chronically treated with drugs acting on brain 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Ondansetron and opiate craving. A novel pharmacological approach to addiction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Receptor mediation of 5-HT-induced inflammation and nociception in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

Closing Remarks: Ondansetron: Effects on Gastrointestinal Motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901349-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(97)01349-6

1 reference

2 November 2017

1 reference